Supply chain management and accessibility to point-of-care testing in resource-limited settings: a systematic scoping review.

Availability Low-and-middle-income countries Point of care diagnostics; supply chain management; accessibility Use

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
24 Jul 2019
Historique:
received: 20 03 2018
accepted: 16 07 2019
entrez: 26 7 2019
pubmed: 26 7 2019
medline: 23 11 2019
Statut: epublish

Résumé

World Health Organization (WHO) has created an essential list of in-vitro diagnostics. Supply chain management (SCM) is said to be the vehicle that ensures that developed point-of-care (POC) tests reach their targeted settings for use. We therefore, mapped evidence on SCM of and accessibility to POC testing (availability and use of POC tests) in low- and middle-income countries (LMICs). We conducted a systematic scoping review using Arksey and O'Malley's framework as a guide. We searched PubMed; CINAHL; MEDLINE; WEB of Science; Science Direct; and Google Scholar databases for studies that focused on POC diagnostic tests and SCM. The review included studies that were undertaken in 140 countries defined by the World Bank as LMICs published up to August 2017. Two reviewers independently screened the abstracts and full articles against the eligibility criteria. The study used the mixed methods appraisal tool version 2011 to assess the risk of bias for the included studies. NVivo version 11 was employed to extract themes from all included studies and results presented using a narrative approach. Of 292 studies identified in this review, only 15 published between 2009 and 2017 included evidence on POC diagnostics and SCM. Of the 15 studies, three were conducted in Zambia, one each in Mozambique, Uganda, Guatemala; South Africa, one in Burkina Faso, Zimbabwe, and one multi-country study (Tanzania, Uganda, China, Peru and Zambia and Brazil). Six studies were not country specific since they were not primary studies. Majority of the studies reported stock-outs of HIV, syphilis, and malaria POC tests. There was a moderate to substantial level of agreement between the reviewers' responses at full article screening stage (Kappa statistic = 0.80, p < 0.01). Nine studies underwent methodological quality appraisal and all, scored between 90 and 100%. The results demonstrated limited published research on SCM of and accessibility to POC testing in LMICs. Further studies aimed at investigating SCM of POC tests in resource-limited settings to identify the barriers/challenges and provide a context-specific evidence-based solutions for policy/decision makers, implementers, and POC developers, funders, and development partners would be essential. CRD42016043711.

Sections du résumé

BACKGROUND BACKGROUND
World Health Organization (WHO) has created an essential list of in-vitro diagnostics. Supply chain management (SCM) is said to be the vehicle that ensures that developed point-of-care (POC) tests reach their targeted settings for use. We therefore, mapped evidence on SCM of and accessibility to POC testing (availability and use of POC tests) in low- and middle-income countries (LMICs).
METHODS METHODS
We conducted a systematic scoping review using Arksey and O'Malley's framework as a guide. We searched PubMed; CINAHL; MEDLINE; WEB of Science; Science Direct; and Google Scholar databases for studies that focused on POC diagnostic tests and SCM. The review included studies that were undertaken in 140 countries defined by the World Bank as LMICs published up to August 2017. Two reviewers independently screened the abstracts and full articles against the eligibility criteria. The study used the mixed methods appraisal tool version 2011 to assess the risk of bias for the included studies. NVivo version 11 was employed to extract themes from all included studies and results presented using a narrative approach.
RESULTS RESULTS
Of 292 studies identified in this review, only 15 published between 2009 and 2017 included evidence on POC diagnostics and SCM. Of the 15 studies, three were conducted in Zambia, one each in Mozambique, Uganda, Guatemala; South Africa, one in Burkina Faso, Zimbabwe, and one multi-country study (Tanzania, Uganda, China, Peru and Zambia and Brazil). Six studies were not country specific since they were not primary studies. Majority of the studies reported stock-outs of HIV, syphilis, and malaria POC tests. There was a moderate to substantial level of agreement between the reviewers' responses at full article screening stage (Kappa statistic = 0.80, p < 0.01). Nine studies underwent methodological quality appraisal and all, scored between 90 and 100%.
CONCLUSIONS CONCLUSIONS
The results demonstrated limited published research on SCM of and accessibility to POC testing in LMICs. Further studies aimed at investigating SCM of POC tests in resource-limited settings to identify the barriers/challenges and provide a context-specific evidence-based solutions for policy/decision makers, implementers, and POC developers, funders, and development partners would be essential.
PROSPERO REGISTRATION NUMBER UNASSIGNED
CRD42016043711.

Identifiants

pubmed: 31340833
doi: 10.1186/s12913-019-4351-3
pii: 10.1186/s12913-019-4351-3
pmc: PMC6657084
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

519

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI108293
Pays : United States

Références

Am J Clin Pathol. 2009 Jun;131(6):867-74
pubmed: 19461096
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 1:S70-2
pubmed: 25968489
J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):e54-9
pubmed: 21857356
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
PLoS Med. 2012;9(6):e1001233
pubmed: 22719229
Lancet Infect Dis. 2014 Mar;14(3):239-49
pubmed: 24332389
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
PLoS One. 2015 Dec 07;10(12):e0141032
pubmed: 26641097
IEEE Pulse. 2011 Nov;2(6):40-50
pubmed: 22147068
Diagnostics (Basel). 2016 Aug 31;6(3):
pubmed: 27589808
Heliyon. 2019 Feb 19;5(2):e01236
pubmed: 30828664
Pathog Glob Health. 2012 Mar;106(1):32-9
pubmed: 22595272
Future Microbiol. 2009 Dec;4(10):1271-82
pubmed: 19995188
Expert Rev Mol Diagn. 2015;15(9):1107-10
pubmed: 26312948
AIDS. 1999 May 28;13(8):951-6
pubmed: 10371176
Malar J. 2014 Aug 02;13:295
pubmed: 25086645
Expert Rev Mol Diagn. 2014 Jun;14(5):525-34
pubmed: 24784765
J Cardiovasc Transl Res. 2014 Nov;7(8):737-48
pubmed: 25294168
Sex Transm Infect. 2006 Dec;82 Suppl 5:v1-6
pubmed: 17151023
Diagnostics (Basel). 2017 Nov 29;7(4):
pubmed: 29186013
BMC Public Health. 2012 Aug 24;12:695
pubmed: 22920954
J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):202-10
pubmed: 12394799
Nat Rev Microbiol. 2006 Dec;4(12 Suppl):S7-19
pubmed: 17110922
Glob Health Sci Pract. 2016 Sep 29;4(3):467-80
pubmed: 27688718
Lancet. 2011 Oct 29;378(9802):1572-9
pubmed: 21951656
PLoS One. 2017 Aug 22;12(8):e0183044
pubmed: 28829801
Lancet. 2010 Jun 19;375(9732):2169-78
pubmed: 20488514
Clin Microbiol Infect. 2013 May;19(5):399-407
pubmed: 23438048
Trop Med Int Health. 2012 Mar;17(3):374-9
pubmed: 22141433
J Trop Med. 2012;2012:651927
pubmed: 22287974
PLoS Med. 2009 Jan 6;6(1):e252
pubmed: 19127974
Eur Respir J. 2016 Aug;48(2):516-25
pubmed: 27418550
PLoS One. 2019 Feb 27;14(2):e0211498
pubmed: 30811407
Nurs Manage. 2005 Feb;36(2):36-8, 40
pubmed: 15702004
BMJ Glob Health. 2016 Dec 2;1(4):e000132
pubmed: 28588980
Indian J Med Res. 2011 Dec;134(6):779-86
pubmed: 22310813
MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4
pubmed: 16988643
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 1:S58-62
pubmed: 25968492
PLoS Med. 2012;9(9):e1001306
pubmed: 22973183
AIDS Care. 2011 Jul;23(7):814-21
pubmed: 21400312
Int Health. 2015 Nov;7(6):384-9
pubmed: 26553825
J Int AIDS Soc. 2016 Jun 30;19(1):20917
pubmed: 27370169
PLoS One. 2015 Jun 01;10(6):e0127728
pubmed: 26030741
EClinicalMedicine. 2019 Jul 03;13:74-80
pubmed: 31517264
BMC Med. 2014 Sep 08;12:173
pubmed: 25197773
Glob Health Sci Pract. 2013 Mar 21;1(1):18-23
pubmed: 25276513
BMC Public Health. 2019 Jun 10;19(1):718
pubmed: 31182068
BMC Pregnancy Childbirth. 2015 Sep 02;15:200
pubmed: 26330022
BMC Health Serv Res. 2018 May 29;18(1):380
pubmed: 29843711
AIDS Patient Care STDS. 2014 May;28(5):268-73
pubmed: 24742299
Clin Infect Dis. 2016 Feb 1;62(3):369-374
pubmed: 26423384
Sex Health. 2015 Apr;12(2):119-25
pubmed: 25622292

Auteurs

Desmond Kuupiel (D)

Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. desmondkuupiel98@hotmail.com.

Vitalis Bawontuo (V)

Faculty of Health and Allied Sciences, Catholic University College of Ghana, Fiapre, Sunyani, Ghana.

Paul K Drain (PK)

International Clinical Research Center, Department of Global Health, University of Washington, Seattle, USA.
Division of Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA.
Department of Epidemiology, University of Washington, Seattle, USA.

Nonjabulo Gwala (N)

Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.

Tivani P Mashamba-Thompson (TP)

Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH